SEI Investments’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
SEI Investments's MRNA Position: Q3 2026 in Review
SEI Investments increased its Moderna (MRNA) stake by 13% in Q3 2026, buying an estimated $1.21M and bringing the position to 95,971 shares worth $18.5M. The position accounts for 0.02% of the portfolio, ranked #808.
SEI Investments first reported a position in MRNA in Q4 2018 and has held it in 26 quarters since. 1,053 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- SEI Investments held 95,971 shares of Moderna worth $18.5M as of Q3 2026.
- SEI Investments bought 11,191 Moderna shares in Q3 2026, an estimated $1.21M.
- Moderna made up 0.02% of SEI Investments's portfolio in Q3 2026, its #808 holding.
- SEI Investments first reported a position in Moderna in Q4 2018 and has held it in 26 quarters since.
- 1,053 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.